Krystal Biotech
KRYS
KRYS
140 hedge funds and large institutions have $1.35B invested in Krystal Biotech in 2021 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 56 increasing their positions, 22 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
140
Holders Change
+27
Holders Change %
+23.89%
% of All Funds
2.16%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
48
Increased
56
Reduced
22
Closed
21
Calls
$17.2M
Puts
$20.3M
Net Calls
-$3.11M
Net Calls Change
-$16.6M
Top Buyers
1 |
Point72 Asset Management
Stamford,
Connecticut
|
$130M |
2 |
ACA
Avoro Capital Advisors
New York
|
$33.2M |
3 |
AG
Artal Group
Luxembourg
|
$49M |
4 |
BBA
Baker Bros. Advisors
New York
|
$56.5M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
$71.6M |